Redoble, Mary Joy D.

HRN: 21-52-52  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2022
AMPICILLIN 1GM (VIAL)
07/04/2022
07/11/2022
IV
2g
Q6H
PROM
Waiting Final Action 
07/05/2022
CEFUROXIME 750MG (VIAL)
07/05/2022
07/08/2022
IV
750mg
Q8H
S/p LTCS
Waiting Final Action 
07/05/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/05/2022
07/08/2022
IV
500mg
Q8H
S/p LTCS
Waiting Final Action 
07/05/2022
CEFUROXIME 500MG (TAB)
07/05/2022
07/11/2022
ORAL
500
BID
S/P LSCS
Waiting Final Action 
07/05/2022
METRONIDAZOLE 500MG (TAB)
07/05/2022
07/11/2022
ORAL
500mg
Q8
S/P LSCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: